Nan, D. et al. 2021. Delayed Use of the Recombinant Human IL-1 Receptor Antagonist Anakinra in Five COVID-19 Patients with Pulmonary Fibrosis and Persistent Hypoxaemia: A Preliminary Report. European Journal of Case Reports in Internal Medicine. 8, 10 (Oct. 2021). DOI:https://doi.org/10.12890/2021_002821.